Overview

Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The study objectives are to characterize new users of Cyproterone Acetate / Ethinylestradiol (CPA/EE) in 2011/2012 and in 2014 according to demographics, treatment characteristics, previous diagnosis of acne, hirsutism or other hyperandrogenic conditions, previous acne treatment and (concomitant) use of hormonal contraceptives identified in Healthcare Databases in the UK (THIN), the Netherlands (PHARMO) and Italy (HSD).
Details
Lead Sponsor:
Bayer
Treatments:
Cyproterone
Cyproterone Acetate
Cyproterone acetate, ethinyl estradiol drug combination
Ethinyl Estradiol